Introduction
During the past 20 years it has become clear that polyarteritis nodosa, as described by Kussmaul & Maier (1866) , is uncommon. In that 'classic' form it is a devastating disease affecting predominantly the larger muscular arteries of the splanchnic organs. However systemic vasculitis involving only the lower orders of the arterial tree is relatively common. Davson and his colleagues (1948) used the term 'microscopic polyarteritis' to describe an arteritis that was detectable only by light microscopy, in contrast to polyarteritis nodosa in which, at autopsy, the vessel involvement was often visible with the naked eye.
Arteritis may occur as part of some well characterized systemic disease such as systemic lupus erythematosus (SLE), Henoch-Schoenlein purpura (HSP), or cryoglobulinaemia. These are most conveniently thought of as secondary forms of arteritis (Neild & Williams 1985) . However, when these conditions affect the kidney it is their glomerular involvement that dominates the picture (Cameron et al. 1979 , Meadows et al. 1972 . In other conditions arteritis appears to be the primary disorder. These primary or idiopathic forms of systemic arteritis will be referred to as polyarteritis. This review is about polyarteritis affecting the kidney Rapidly progressive glomerulonephritis (RPGN) is the most serious manifestation of polyarteritis involving the kidney. RPGN is a rare syndrome characterized (1) clinically by an acute nephritic syndrome with the rapid development of renal failure, and (2) pathologically by a severe crescentic glomerulonephritis. Many patients who present with RPGN have a clinical illness suggestive of a vasculitis (Neild et al. 1983 ). Davson et al. (1948) were the first to propose that necrotizing glomerulonephritis with crescents might be the sole renal manifestation of polyarteritis. This concept was accepted, and recently Serra et al. (1984) confirmed in a study of renal vasculitis that there were no clinical differences between those in whom vasculitis was apparently confined to the glomerulus and those who had a histologically proven arteritis elsewhere.
Definitions
Necrotizing polyarteritis is a systemic vasculitis predominantly involving arteries. There are two componentsa cellular reaction involving all three layers of the vessel wall and fibrinoid necrosis of the media. The former consists predominantly of mononuclear cells, but when necrosis occurs polymorphs are prominent in the cellular reaction. In some forms of arteritis the mononuclear cells form granulomata adjacent to the vessel wallhence 'granulomatous arteritis'. In another form of arteritis giant cells are found in this mononuclear reaction, usually in association with rupture of the elastic laminahence 'giant cell arteritis'. Giant cell arteritis affecting the kidney has been described in a few case reports but is very rare (O'Neill et al. 1976) .
Patients with polyarteritis present in many ways and are a heterogeneous group, but various clinicopathological syndromes or subgroups have been described in which the disease can be clearly defined. The most common of these is Wegener's granulomatosis. In this syndrome there is a granulomatous arteritis that preferentially involves the upper and lower respiratory tract and the kidneys. However, the renal involvement of Wegener's is indistinguishable from 'Accepted 26 March 1985 0 5/ 1985 The Royal Society of Medicine 0141-0768/85/080667-05/$02.00/0 other primary forms of polyarteritis and will not be considered separately (Fauci et al. 1983 , Pinching et al. 1983 . Similarly, polyarteritis may be associated with a history of allergic rhinitis, asthma and eosinophilia -'Churg-Strauss syndrome' (Lanham et al. 1984) . Pathology of renal vasculitis Glomerular involvement is common in microscopic polyarteritis. Acutely, there is a focal and segmental necrotizing glomerulonephritis and this is typically associated with extracapillary proliferation ('crescents'). Apart from the segmental areas of necrosis there is little or no proliferation of the glomerular tuft. When glomerular involvement is severe, there may be rupture and necrosis of Bowman's capsule. There is a variable degree of interstitial mononuclear cell infiltration (Sonsino et al. 1972 , Serra et al. 1984 . Immunoperoxidase or immunofluorescent examination of the glomeruli shows no consistent deposition of immunoglobulins or complement, although there may be fibrin and some nonspecific immunoglobulins at sites of necrosis (Ronco et al. 1983) . Similarly, electron microscopy shows no electron-dense deposits. In RPGN, usually more than 50% of glomeruli have large crescents covering at least 50% of the circumference.
When the illness is more chronic, glomeruli may show segmental or total sclerosis; crescents may be fibrocellular or fibrosed. There may be extensive tubular atrophy and interstitial fibrosis. Renal arteritis is found at autopsy in almost every case with a clinical history of vasculitis, but an arteritis is found in renal biopsy specimens in only one-third of these cases (Serra et al. 1984) .
Rarely renal failure is due to segmental infarction of the kidney. Typically this form of injury leads to hypertension, which may be severe. Vasculitis of the ureter, bladder, epididymis and testis are rare, but may lead to pain, haematuria, haemospermia and even infarction of these organs. Histopathological differential diagnosis There are other conditions associated with systemic vascular injury in which the renal vascular injury may lead to severe renal failure. There are only a limited number of ways in which a blood vessel may respond to injury and any severe injury may lead to (1) necrosis of the vessel wall, (2) intimal expansion due to oedema, insudation of plasma proteins and red cells, and (3) luminal stenosis or thrombosis. These changes are usually associated with either glomerular ischaemia and collapse due to the compromised afferent arteriole, or glomerular thrombosis due to the vascular injury extending into the glomerulus. This appearance (malignant nephrosclerosis) may be caused by the haemolytic uraemic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), post-partum renal failure or systemic sclerosis, or there may be malignant ('accelerated') hypertension with evidence of previous hypertension (Bohle et al. 1976 , Sinclair et al. 1976 ). These conditions principally affect the smaller arteries and glomeruli; large artery involvement is usually associated with scleroderma or malignant hypertension. It is only when renal damage is very severe or chronic that these various conditions are likely to be confused with polyarteritis.
When polyarteritis is manifest solely by crescentic glomerulonephritis, the differential diagnosis from other forms of glomerulonephritis may be more difficult. It is important to examine carefully the glomeruli which are least affected. The presence of diffuse glomerular proliferation signifies some primary or secondary form of glomerulonephritis and this can be categorized further by the immunoperoxidase and ultrastructural appearance (Neild et al. 1983) .
In antiglomerular basement membrane (anti-GBM) antibody disease, necrosis may be so extensive that no comment can be made on the glomerular architecture and the linear deposits of IgG on the GBM may be lost. In RPGN, serum should always be examined for anti-GBM antibodies.
Aetiology and pathogenesis
There are few clues to the aetiology. In 10% of cases a drug can be implicated. In up to 10% there is an associated neoplasmusually a lymphoproliferative disorder such as lymphoma, hairy cell leukaemia or myeloma. Hepatitis B infection does not appear to be associated with renal vasculitis (for review see Serra & Cameron 1985) . Virtually nothing is known of the pathogenesis. Immune complexes can be found by various techniques in the majority of cases (Ronco et al. 1983 ), but there is no histological evidence to suggest that renal vaculitis is an immune complex disease. On the contrary, the cellular reaction, particularly associated with granulomatous vasculitis, is more suggestive of a cellmediated disease; and the cells that constitute crescents are monocyte/macrophages and not proliferated epithelial cells (Atkins et al. 1982) .
Diagnosis
Involvement of the kidneys is common in polyarteritis and occurs in up to 85% of all cases. It is associated with a poor prognosis. Patients may present with extrarenal symptoms but be found to have renal involvement manifest as microscopic haematuria and proteinuria, with or without a raised plasma creatinine. In such cases a renal biopsy should show the typical glomerular changes, although these may be mild in keeping with the clinical picture.
Clinical: Polyarteritis is uncommon in non-whites. The mean age of onset is in the fifth decade; there is a slight male preponderance. When renal involvement is the presenting feature, it is usually the predominant feature. In such cases there is severe glomerular involvement. Patients may present with oliguria and severe renal insufficiency. Few with oliguria recover renal function. All have either macroscopic haematuria or heavy microscopic haematuria which is usually of sufficient degree to discolour the urine ( > 100 red cells/mm3). Patients may be oedematous from salt and water retention and the albumin level is usually suppressed below 30 g/l, but it is rare to have proteinuria of more than 3 g/day and be truly nephrotic. When vasculitis and the nephrotic syndrome occur together they are usually due to some other systemic disease such as SLE, subacute bacterial endocarditis or cryoglobulinaemia.
There may be clear evidence of a multisystem disease with involvement of other organs such as the eyes, skin or lungs. The diagnosis of polyarteritis may be suspected when there has been a typical prodrome, for several weeks, of vague malaise, tiredness, fever, weight loss and often more specific features such as myalgia and arthralgia. At presentation, hypertension is not a prominent feature and when accompanied by renal insufficiency is usually attributable to salt and water retention.
Laboratory: Laboratory results are consistent with an acute-phase protein response, and blood tests essentially exclude other conditions such as SLE and anti-GBM disease. In severe cases the haemoglobin (Hb) is reduced to 8-10 g/dl. A Hb below 8 g/dl may indicate gut or lung haemorrhage and should make one suspicious of Goodpasture's syndrome. The white count is raised (10-20 x 109/1) with a neutrophil leukocytosis. Eosinophilia (>1 x 109/1) is uncommon and is often associated with a myocarditis. Thrombocytosis (>500 x I09 platelets/l) occurs in 20-30%. When it does occur it is a useful marker of disease activity. The ESR is usually around 100 mm/h. C-reactive protein is raised. Gammaglobulin levels are diffusely raised. A rheumatoid factor is positive in 30-40% of cases. Complement levels are normal or raised (low levels of complement suggest some other systemic disease such as SLE, or bacterial endocarditis). The hepatitis B antigen should always be looked for, but in the UK evidence of hepatitis B infection is found in less than 10% of cases. Serum should always be examined for anti-GBM antibodies, as well as antinuclear factor (ANF), and double stranded anti-DNA antibodies. Blood cultures are taken, repeatedly if endocarditis is a possibility. The diagnosis is established with a renal biopsy and this should be performed within 24 hours.
Treatment and management
Polyarteritis is a serious disease. Prompt and adequate treatment is essential, since few kidneys are salvaged once they are oliguric. In contrast, it is relatively common for kidneys to recover if the underlying lesion is a proliferative glomerulonephritis. The aggressiveness of the treatment directed at the kidneys should match the histological severity of the disease. For severe crescentic disease, both steroids and an immunosuppressive drug are necessary. High-dose oral prednisolone should be given in an initial dose of about 60 mg/day (35 mg/m2/day) together with either azathioprine or cyclophosphamide in a dose of 2-2.5 mg/kg/day. Azathioprine has the merit of being relatively safe in both the short and long term, with marrow suppression and other side effects being unusual at this dose. Cyclophosphamide is perhaps more efficacious in Wegener's granulomatosis, and sometimes this disease may not be controlled by azathioprine but will respond to cyclophosphamide (Fauci et al. 1979 ). However, cyclophosphamide is more toxic than azathioprine and commonly causes marrow suppression, alopecia and haemorrhagic cystitis. After three months gonadal failure occurs and conversion to azathioprine is appropriate (Fairley et al. 1972) .
During the acute phase of the disease, high-dose intravenous 'pulses' of methylprednisolone may be beneficial (Bolton & Couser 1979) . It is likely that their action is principally antiinflammatory. Usually 0.5-1 g is given on three consecutive days. When the disease is not controlled by these measures, plasmapheresis has been advocated. It may be of particular value when the patient is oliguric (Hind et al. 1983) . Without plasmapheresis, very few anuric patients have recovered renal function. In such patients, if there is no sign of recovery after 3-4 weeks, immunosuppressive treatment should be reserved for controlling extrarenal vasculitis. Combined immunosuppression and plasmapheresis is associated with a high mortality from infection (Hind et al. 1983) .
As the disease is controlled, the prednisolone dose can usually be tapered over 2-3 months to 20 mg/day (12 mg/m2/day). Over the next 2-3 months the dose should be tapered more slowly to a maintenance dose of 10-15 mg/day. Side effects, such as a cushingoid appearance or myopathy, may be reduced if the drug is given on alternate days. After two years of disease inactivity, an attempt can be made to wean the patient off the steroids and immunosuppressive drugs.If the disease is in remission, an earlier tapering or withdrawal of prednisolone has been recommended (Fauci et al. 1979) .
Assessment of disease activity can be difficult, particularly when the kidneys are the prime site of injury. Indices of renal activity are changes in proteinuria, haematuria and renal function. Function must be monitored closely and accurately, and ideally the glomerular filtration rate should be measured by radionucleotides, e.g. 51Cr-EDTA. Otherwise, apart from overt clinical signs of activity in other organs, blood tests such as haemoglobin, ESR and C-reactive protein are followed (Hind et al. 1984) .
Prognosis
In untreated polyarteritis there is a five-year survival of 13% of patients. With corticosteroid therapy there is a five-year survival of 50%; with steroids plus an immunosuppressive agent the survival rises to 80% or more (Neild & Williams 1985) . Part of the mortality in former years was related to the poorly controlled hypertension which developed as a sequel to the renal injury.
Less is known about the prognosis of renal vasculitis. Serra and her colleagues (1984) reviewed 53 patients with renal vasculitis seen in one renal unit from 1964-1983. Twenty died early in the disease from active vasculitis, infection and uraemia. Fifteen died later. The prognosis was worst in those with oliguria and extensive crescents. Patient survival was 54%, 38% and 34% at one, 5 and 10 years respectively. Of those who survived the initial disease, 12 were stable with apparently inactive disease, and after a mean follow up to 60 months 11 were still alive; 16 had continuing signs of activity requiring treatment and only 5 were alive after a mean of 27 months; and 2 patients developed recurrent acute vasculitis 12 and 48 months after stopping all drugs.
Conclusion
Renal vasculitis can be a very unpleasant disease. Early biopsy is essential for diagnosis and management. Few kidneys that become oliguric will be salvaged.
